A prospective study on 2241 adults without diabetes found higher plasma levels of butyrate and isobutyrate, two short-chain fatty acids (SCFAs), to be early biomarkers of type 2 diabetes risk. This suggests that SCFAs, particularly butyrate and isobutyrate, may serve as early markers of systemic metabolic dysfunction, influencing diabetes risk stratification.

Source: BMC Medicine